Status:
ACTIVE_NOT_RECRUITING
LIver FRAilty Management IN Cirrhosis (LIFRAMIN)
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Sarcopenia
Cirrhosis, Liver
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare food for special medical purposes (Aminolife Plus, by Piemme Pharmatech) vs. placebo in improving muscle mass and function in a cohort of cirrhotic patien...
Detailed Description
patients will be randomly allocated within the two groups: 1. nutritional counselling according to guidelines + Aminolife plus 20 g/day (4 scoops) vs. 2. nutritional counselling according to guidelin...
Eligibility Criteria
Inclusion
- Patients affected by Liver cirrhosis
- at any stage of Child (A-B-C) with or without hepatocarcinoma
- SARC-F suggestive of risk of sarcopenia
- Age \> 18 years
- Ability to perform Liver Frailty Index test
- Informed consent to participate in the study.
Exclusion
- SARC-F not suggestive of sarcopenia
- inability to perform Liver Frailty Index test
- absence of informed consent
Key Trial Info
Start Date :
August 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06573229
Start Date
August 2 2024
End Date
October 30 2025
Last Update
August 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emanuele Rinninella
Rome, Italy, 00168